{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:20:32Z","timestamp":1794932432319,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221710\/Z\/20\/Z"],"award-info":[{"award-number":["221710\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000849","name":"National Centre for the Replacement Refinement & Reduction of Animals in Research","doi-asserted-by":"publisher","award":["NC\/X001172\/1"],"award-info":[{"award-number":["NC\/X001172\/1"]}],"id":[{"id":"10.13039\/501100000849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010757","name":"National Centre for the Replacement Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/S03398X\/1"],"award-info":[{"award-number":["MR\/S03398X\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129074","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:10:32Z","timestamp":1787800232000},"page":"129074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Virus-like particle display of consensus \u03b1-neurotoxins does not enhance neutralising antibody responses against elapid venoms"],"prefix":"10.1016","volume":"91","author":[{"given":"Rebecca J.","family":"Edge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Stars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura O.","family":"Albulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd D.W.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0005","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000860","article-title":"Annual incidence of snake bite in rural Bangladesh","volume":"4","author":"Rahman","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129074_bb0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.trstmh.2005.09.003","article-title":"Underestimation of snakebite mortality by hospital statistics in the Monaragala District of Sri Lanka","volume":"100","author":"Fox","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129074_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/trstmh\/trae106","article-title":"Primary health system strengthening and system-level interventions for tackling snakebite envenoming in India","volume":"119","author":"Kadam","year":"2025","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/15563650.2021.1943427","article-title":"The clinical course and treatment of black mamba (Dendroaspis polylepis) envenomations: a narrative review","volume":"59","author":"Aalten","year":"2021","journal-title":"Clin Toxicol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000851","article-title":"Pre-clinical assays predict Pan-African Echis viper efficacy for a species-specific antivenom","volume":"4","author":"Casewell","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129074_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009247","article-title":"Biogeographic venom variation in Russell\u2019s viper (<i>Daboia russelii<\/i>) and the preclinical inefficacy of antivenom therapy in snakebite hotspots","volume":"15","author":"Senji Laxme","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/14789450.2018.1528150","article-title":"Proteomic analysis reveals geographic variation in venom composition of Russell\u2019s viper in the Indian subcontinent: implications for clinical manifestations post-envenomation and antivenom treatment","volume":"15","author":"Kalita","year":"2018","journal-title":"Expert Rev Proteomics"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012570","article-title":"Intraspecific venom variation in the medically important puff adder (Bitis arietans): comparative venom gland transcriptomics, in vitro venom activity and immunological recognition by antivenom","volume":"18","author":"Dawson","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129074_bb0055","first-page":"14","article-title":"An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms","volume":"10","author":"Chan","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2026.129074_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giac121","article-title":"High-throughput proteomics and <i>in vitro<\/i> functional characterization of the 26 medically most important elapids and vipers from sub-Saharan Africa","volume":"11","author":"Nguyen","year":"2022","journal-title":"Gigascience"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32174-7","article-title":"The molecular mechanism of snake short-chain \u03b1-neurotoxin binding to muscle-type nicotinic acetylcholine receptors","volume":"13","author":"Nys","year":"2022","journal-title":"Nat Commun"},{"issue":"S2","key":"10.1016\/j.vaccine.2026.129074_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.13975","article-title":"The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions","volume":"142","author":"Kessler","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.vaccine.2026.129074_bb0075","doi-asserted-by":"crossref","unstructured":"Ranawaka UK, Lalloo DG, Silva HJ de. Neurotoxicity in snakebite\u2014the limits of our knowledge. PLoS Negl Trop Dis 2013;7(10):e2302. doi:https:\/\/doi.org\/10.1371\/journal.pntd.0002302.","DOI":"10.1371\/journal.pntd.0002302"},{"key":"10.1016\/j.vaccine.2026.129074_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114168","article-title":"Snake three-finger \u03b1-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicine","author":"Nirthanan","year":"2020","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.vaccine.2026.129074_bb0085","doi-asserted-by":"crossref","unstructured":"Ainsworth S, Petras D, Engmark M, S\u00fcssmuth RD, Whiteley G, Albulescu LO, et al. The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms. J Proteomics 2018;172:173\u201389. doi:https:\/\/doi.org\/10.1016\/j.jprot.2017.08.016 [PubMed PMID: 28843532].","DOI":"10.1016\/j.jprot.2017.08.016"},{"issue":"6527","key":"10.1016\/j.vaccine.2026.129074_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.abb9303","article-title":"Convergent evolution of pain-inducing defensive venom components in spitting cobras","volume":"371","author":"Kazandjian","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129074_bb0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"issue":"24","key":"10.1016\/j.vaccine.2026.129074_bb0100","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1093\/nar\/26.24.5624","article-title":"Genetic characterization of the mRNAs encoding alpha-bungarotoxin: isoforms and RNA editing in Bungarus multicinctus gland cells","volume":"26","author":"Liu","year":"1998","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129074_bb0105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129074_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12030205","article-title":"An appetite for destruction: detecting prey-selective binding of \u03b1-neurotoxins in the venom of afro-Asian elapids","volume":"12","author":"Harris","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129074_bb0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00726-018-2556-0","article-title":"Short-chain consensus alpha-neurotoxin: a synthetic 60-mer peptide with generic traits and enhanced immunogenic properties","volume":"50","author":"de la Rosa","year":"2018","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0120","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1038\/s41467-019-11639-2","article-title":"Horse immunization with short-chain consensus \u03b1-neurotoxin generates antibodies against broad spectrum of elapid venomous species","volume":"10","author":"de la Rosa","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2522838","article-title":"Discovery of broadly neutralizing VHHs against short-chain \u03b1-neurotoxins using a consensus toxin as an antigen","volume":"17","author":"Damsbo","year":"2025","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat Commun"},{"issue":"735","key":"10.1016\/j.vaccine.2026.129074_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1867","article-title":"Synthetic development of a broadly neutralizing antibody against snake venom long-chain \u03b1-neurotoxins","volume":"16","author":"Khalek","year":"2024","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.vaccine.2026.129074_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.peptides.2016.12.006","article-title":"Synthetic peptide antigens derived from long-chain alpha-neurotoxins: immunogenicity effect against elapid venoms","volume":"88","author":"de la Rosa","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.vaccine.2026.129074_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2024.100204","article-title":"Plug and play virus-like particles for the generation of anti-toxin antibodies","volume":"23","author":"Edge","year":"2024","journal-title":"Toxicon X"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129074_bb0150","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol Biol Evol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129074_bb0155","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129074_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008579","article-title":"An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management","volume":"14","author":"Ainsworth","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129074_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001144","article-title":"Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea","volume":"5","author":"Vargas","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129074_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288723","article-title":"Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: a systematic review","volume":"18","author":"Soopairin","year":"2023","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129074_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00204-023-03643-9","article-title":"Systematic review and meta-analysis on the efficacy of Indian polyvalent antivenom against the Indian snakes of clinical significance","volume":"98","author":"Gopal","year":"2024","journal-title":"Arch Toxicol"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129074_bb0180","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2026.129074_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115758","article-title":"An in vitro assay to investigate venom neurotoxin activity on muscle-type nicotinic acetylcholine receptor activation and for the discovery of toxin-inhibitory molecules","volume":"216","author":"Patel","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129074_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005969","article-title":"Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa","volume":"11","author":"Harrison","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129074_bb0195","author":"WHO"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48539-z","article-title":"In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model","volume":"15","author":"Benard-Valle","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129074_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030184","article-title":"Bioinformatics and multiepitope DNA immunization to design rational Snake antivenom","volume":"3","author":"Wagstaff","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.129074_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.108056","article-title":"Composition, pharmacology, and pathophysiology of the venom of monocled cobra (Naja kaouthia)- a medically crucial venomous snake of Southeast Asia: an updated review","volume":"249","author":"Kakati","year":"2024","journal-title":"Toxicon Off J Int Soc Toxinology"},{"issue":"120","key":"10.1016\/j.vaccine.2026.129074_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jprot.2015.02.012","article-title":"Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia","volume":"29","author":"Tan","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.vaccine.2026.129074_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103463","article-title":"Proteomics of Naja kaouthia venom from north East India and assessment of Indian polyvalent antivenom by third generation antivenomics","volume":"207","author":"Deka","year":"2019","journal-title":"J Proteomics"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129074_bb0225","article-title":"Beyond the \u2018big four\u2019: venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies","volume":"13","author":"Laxme","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129074_bb0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jprot.2016.06.018","article-title":"Top-down venomics of the east African green mamba, Dendroaspis angusticeps, and the black mamba, Dendroaspis polylepis, highlight the complexity of their toxin arsenals","volume":"146","author":"Petras","year":"2016","journal-title":"J Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129074_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-025-01600-4","article-title":"Structural mechanisms behind the neutralisation of long-chain \u03b1-neurotoxins by broadly neutralising VHHs discovered using a consensus antigen","volume":"8","author":"Damsbo","year":"2025","journal-title":"Commun Chem"},{"key":"10.1016\/j.vaccine.2026.129074_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2024.100212","article-title":"Stress levels, hematological condition, and productivity of plasma-producing horses used for snake antivenom manufacture: a comparison of two industrial bleeding methods","volume":"24","author":"Arias-Esquivel","year":"2024","journal-title":"Toxicon X."},{"key":"10.1016\/j.vaccine.2026.129074_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100233","article-title":"Comparison of adjuvant emulsions for their safety and ability to enhance the antibody response in horses immunized with African snake venoms","volume":"12","author":"Arguedas","year":"2022","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2026.129074_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2026.109145","article-title":"Inter-individual variability in equine antibody responses to African snake venoms follows heavy-tailed distributions with implications for antivenom production","volume":"279","author":"S\u00e1nchez","year":"2026","journal-title":"Toxicon"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129074_bb0255","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41577-021-00567-2","article-title":"Using cross-species vaccination approaches to counter emerging infectious diseases","volume":"21","author":"Warimwe","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129074_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2016.02.003","article-title":"Distinct antibody species: structural differences creating therapeutic opportunities","volume":"40","author":"Muyldermans","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"732","key":"10.1016\/j.vaccine.2026.129074_bb0265","article-title":"A consensus recombinant elapid long-chain \u03b1-neurotoxin and how protein folding matters for antibody recognition and neutralization of elapid venoms","volume":"5","author":"Carpanta","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"10.1016\/j.vaccine.2026.129074_bb0270","doi-asserted-by":"crossref","first-page":"18211","DOI":"10.1021\/acsami.9b21776","article-title":"A self-adjuvanted, modular, antigenic VLP for rapid response to influenza virus variability","volume":"12","author":"Sharma","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129074_bb0275","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129074_bb0280","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bit.25159","article-title":"Bioengineering virus-like particles as vaccines","volume":"111","author":"Lua","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2026.129074_bb0285","series-title":"WHO expert committee on biological standardization: sixty-seventh report","author":"WHO","year":"2017"},{"key":"10.1016\/j.vaccine.2026.129074_bb0290","series-title":"Improving&nbsp;in vivo&nbsp;assays in snake venom and antivenom research: a community discussion [internet]. F1000Res","author":"Marriott","year":"2024"},{"key":"10.1016\/j.vaccine.2026.129074_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.830384","article-title":"Rodent lethality models are problematic for evaluating antivenoms for human envenoming","volume":"13","author":"Silva","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:50:24Z","timestamp":1794930624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S0264410X26008832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particle display of consensus \u03b1-neurotoxins does not enhance neutralising antibody responses against elapid venoms","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129074"}}